Skip to content
Thursday, August 21, 2025
  • Home
  • BCS News
    • Latest from BCS
    • BCS Editorials
    • Obituaries
    • Editors
  • COVID-19
  • BCS Home

Latest News

  • Impella, build it and the evidence will come…?

  • There is benefit to communicating CVD risk with patients: A meta-analysis

  • Patients with heart failure: Virtual wards

  • Cardiac waiting lists: An outlier or some progress? Part V

  • Apixaban reduces the risk of stroke in device-detected subclinical atrial fibrillation

  • The diagnostic yield of NT-proBNP in a regional heart failure pathway

  • Do patients with minimally symptomatic severe aortic stenosis benefit from TAVI?

  • Latest News News

    Impella, build it and the evidence will come…?

    By Dr Jonathan ShurlockEdited by Dr Nitin Chandra Mohan The results of the DanGer Shock trial were recently presented at the American College of Cardiology…

    CardioNewsUK 15 April 2024
    View More
  • Latest News News

    There is benefit to communicating CVD risk with patients: A meta-analysis

    By Dr Jonathan Shurlock Edited by Dr. Ahmed El-Medany A meta-analysis from Dr Mina Bakhit (@Mina_Bakhit) and colleagues has explored the role of cardiovascular disease (CVD)…

    CardioNewsUK 8 February 2024
    View More
  • Latest News News

    Patients with heart failure: Virtual wards

    By Dr Jonathan Shurlock Edited by Dr. Ahmed El-Medany NHS England have published data related to ‘virtual wards’, which since October have been a recommended option…

    CardioNewsUK 7 February 2024
    View More
  • Latest News News

    Cardiac waiting lists: An outlier or some progress? Part V

    By Dr Jonathan Shurlock Edited by Dr. Ahmed El-Medany Each of our previous reports have described the continued growth of cardiac waiting lists, including when we…

    CardioNewsUK 6 February 2024
    View More
  • Latest News News

    Apixaban reduces the risk of stroke in device-detected subclinical atrial fibrillation

    By Dr. Florence Mouy Edited by Dr. Ahmed El-Medany The ARTESIA trial (Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Sub-Clinical Atrial Fibrillation) has…

    CardioNewsUK 5 December 2023
    View More

Featured

  • BCS Editorials Latest News

    European Society of Cardiology Heart Failure Guidelines 2021: What should we be doing in current practice?

    CardioNewsUK 23 December 2021
  • Echocardiogram Hypertension
    BCS Editorials Latest News

    AF screening and thromboembolic risk: How much AF is significant?

    CardioNewsUK 22 December 2021
  • exercise in park
    BCS Editorials

    Exercise as a treatment: do we talk about it enough in Hypertension Management?

    CardioNewsUK 21 December 2021
  • IHD resource BMJ
    Latest News News Society News & Announcements

    Resources on Ischemic Heart Disease

    CardioNewsUK 25 October 2021
  • Year in Cardiology Course
    Latest News News Society News & Announcements

    Year in Cardiology Course

    CardioNewsUK 22 October 2021
  • Health Inequalities by UK region
    COVID-19 News Society News & Announcements

    Inequalities in Health Alliance calls on Prime Minister to reduce health inequalities.

    CardioNewsUK 16 September 2021
  • Graphical-demonstration-of-the-reduction-in-waist-circumference
    Latest News Other Categories Research & Trials Society News & Announcements

    In case you missed it: a summary of the BCS ’21 top 10 trials (Part II)

    CardioNewsUK 17 August 2021
  • Procedure
    COVID-19 Devices Latest News News Other Categories Society News & Announcements

    Anticoagulation of Patients with Mechanical Heart Valves.

    CardioNewsUK 9 August 2021

Latest News News

Fewer than 1-in-10 “statin-related” muscle pains are caused by statins

CardioNewsUK 12 September 2022

By Dr. Timothy Swinn, edited by Dr. Ahmed El-Medany A recent meta-analysis published in the Lancet[1] has concluded that fewer than 1 in 15 muscle…

View More Fewer than 1-in-10 “statin-related” muscle pains are caused by statins
Latest News News

Aspirin or P2Y12 inhibitor for coronary artery disease?

CardioNewsUK 7 September 2022

By Dr. Jonathan Shurlock, edited by Dr. Ahmed El-Medany Professor Marco Valgimigli presented the findings of the PANTHER analysis at the 2022 ESC congress. Currently…

View More Aspirin or P2Y12 inhibitor for coronary artery disease?
Latest News News

AVDOR: The resurrection of acetazolamide

CardioNewsUK 4 September 2022

By Dr. Aswin Babu, edited by Dr. Ahmed El-Medany At the most recent European Society of Cardiology (ESC) congress, the results of the AVDOR (Acetazolamide…

View More AVDOR: The resurrection of acetazolamide
Latest News News

DELIVER trial: Dapagliflozin reduces hospitalisation or cardiovascular death in patients with HFpEF and HFmrEF

CardioNewsUK 1 September 2022

By Dr. Timothy Swinn, edited by Dr. Ahmed El-Medany Recent evidence from the DELIVER trial[1], published in the New England Journal of Medicine and presented…

View More DELIVER trial: Dapagliflozin reduces hospitalisation or cardiovascular death in patients with HFpEF and HFmrEF
Latest News News

REVIVED-BCIS2: Cardiologists’ reactions around the Globe

CardioNewsUK 1 September 2022

Collated by Dr. Oliver Jones, edited by Dr. Ahmed El-Medany The bombshell results of REVIVED-BCIS landed this week at ESC 2022. BCS Heartbeat has reactions…

View More REVIVED-BCIS2: Cardiologists’ reactions around the Globe
Latest News News

SECURE Polypill trial: New life for an old idea

CardioNewsUK 30 August 2022

By Dr. Oliver Jones, edited by Dr. Ahmed El-Medany Key points: A polypill containing aspirin, ramipril, and atorvastatin was effective in reducing a composite of…

View More SECURE Polypill trial: New life for an old idea
Latest News News

PCI no better than OMT in severe Ischaemic Cardiomyopathy: REVIVED-BCIS2

CardioNewsUK 29 August 2022

By Dr. Ahmed El-Medany Key points: PCI does not reduce all-cause mortality or heart failure hospitilisation ins patients with severe LVSD and extensive CAD, and…

View More PCI no better than OMT in severe Ischaemic Cardiomyopathy: REVIVED-BCIS2
Latest News News

PCI provides no prognostic benefit in patients undergoing TAVR

CardioNewsUK 24 August 2022

By Dr. Aswin Babu Coronary artery disease (CAD) and aortic stenosis often co-exist and the management of CAD in this cohort of patients remains contentious.…

View More PCI provides no prognostic benefit in patients undergoing TAVR
Latest News News

Enhanced smartphone-based blood pressure monitoring is not superior to standard approaches

CardioNewsUK 24 August 2022

By Dr Jonathan Shurlock In recent years many healthcare providers have explored the role of remote monitoring of patient groups and this idea is widespread…

View More Enhanced smartphone-based blood pressure monitoring is not superior to standard approaches
Latest News News

Revisiting antibiotic prophylaxis for infective endocarditis prior to dental procedures

CardioNewsUK 24 August 2022

By Dr Jonathan Shurlock, edited by Dr. Ahmed El-Medany Guidelines regarding antibiotic prophylaxis for infective endocarditis prior to dental procedures vary across the world. The…

View More Revisiting antibiotic prophylaxis for infective endocarditis prior to dental procedures

Posts navigation

Previous page Page 1 … Page 11 Page 12 Page 13 … Page 24 Next page

Video

https://youtu.be/jpDhCKcM7ak

RSS Heart Journal

  • Terminal renal failure as a contributor to high-sensitivity cardiac troponin T elevations: insights from patients undergoing renal transplantation
  • Perceived health, psychological distress and quality of life in 8415 adults with congenital heart disease from 32 countries
  • Determining kidney function-specific thresholds for N-terminal pro-B-type natriuretic peptide in heart failure risk prediction among patients with chronic kidney disease: a multicentre, observational, cohort study
  • Inflammation in coronary atherosclerosis: diagnosis and treatment
  • Catheter ablation versus medical rate control for persistent atrial fibrillation in older heart failure patients with reduced ejection fraction

RSS AHA Journal Feed

  • Effects of Alcohol Septal Ablation on Exercise Hemodynamics, Symptoms, and Quality of Life in Obstructive Hypertrophic Cardiomyopathy
  • Impact of Peridevice Leak on Clinical Outcomes After Left Atrial Appendage Closure: The OCEAN‐LAAC Registry
  • Evolocumab Added to Statin Is Associated With Intracranial Atherosclerotic Plaque Regression Compared With Statin Alone
  • Modifiable Factors and 10‐Year and Lifetime Risk of Cardiovascular Disease in Adults With New‐Onset Diabetes: The Kailuan Cohort Study
  • Improving “No‐Reflow” After Complete Reperfusion: The Role of Intravenous Thrombolysis in Vertebrobasilar Artery Occlusion Patients Undergoing Endovascular Treatment
UK Cardiology News |
British Cardiovascular Society
✕
BCS Heartbeat

FREE
VIEW